印度尼西亚巴布亚地区脾切除术后间日疟高风险
该研究在印度尼西亚巴布亚一家医院回顾2004-2013年10774例住院患者,其中67例接受脾切除术,并前瞻随访2015-2016年因创伤脾切除患者14个月。脾切除患者12个月内疟疾就诊率是非脾切除住院患者的5倍,间日疟风险更高(AHR 7.8),作者认为疟疾流行区脾切除后应根治间日疟休眠子并预防疟疾。
要点
- 脾切除患者12个月内疟疾就诊风险是非脾切除住院患者的5倍(AHR 5.0)。
- 间日疟风险(AHR 7.8)高于恶性疟(AHR 3.0),均P<.001。
- 作者认为疟疾流行区脾切除后应使用伯氨喹根治间日疟休眠子并预防疟疾。
核心结论
- 脾切除与疟疾高风险相关,间日疟风险高于恶性疟。
- 作者认为疟疾流行区脾切除后应使用伯氨喹根治间日疟休眠子并进行后续疟疾预防。
研究设计与样本
- 回顾2004-2013年印度尼西亚巴布亚Mitra-Masyarakat医院全部就诊患者记录,识别脾切除患者。
- 比较脾切除患者与非脾切除患者自首次记录住院起12个月内特定临床结局风险。
- 前瞻随访2015-2016年因创伤脾切除患者14个月。
主要发现
- 2004-2013年10774例住院患者中67例接受脾切除。
- 脾切除患者12个月内疟疾就诊率是非脾切除住院患者的5倍(AHR 5.0,95%CI 3.4-7.3,P<.001)。
- 间日疟AHR 7.8(95%CI 5.0-12.3),恶性疟AHR 3.0(95%CI 1.7-5.4),均P<.001。
- 脾切除患者因任何原因住院风险更高(AHR 1.8,95%CI 1.0-3.0,P=.037),腹泻住院风险更高(AHR 3.5,95%CI 1.3-9.6,P=.016)。
- 14个月前瞻队列中11例脾切除患者观察到12次间日疟发作和6次恶性疟发作。
临床怎么用
- 作者认为疟疾流行区脾切除后应使用伯氨喹根治间日疟休眠子并进行后续疟疾预防。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Splenectomy increases the risk of severe and fatal infections; however, the risk of Plasmodium vivax malaria is unknown. We quantified the Plasmodium species-specific risks of malaria and other outcomes following splenectomy in patients attending a hospital in Papua, Indonesia. METHODS: Records of all patients attending Mitra-Masyarakat Hospital 2004-2013 were reviewed, identifying those who underwent splenectomy. Subsequent risks of specific clinical outcomes within 12 months for splenectomized patients were compared to nonsplenectomized patients from their first recorded hospital admission. In addition, patients splenectomized for trauma 2015-2016 were followed prospectively for 14 months. RESULTS: Of the 10774 patients hospitalized during 2004-2013, 67 underwent splenectomy. Compared to nonsplenectomized inpatients, patients undergoing splenectomy had a 5-fold higher rate of malaria presentation within 12 months (adjusted hazard ratio [AHR] = 5.0 [95% confidence interval (CI): 3.4-7.3], P < .001). The AHR was 7.8 (95% CI: 5.0-12.3) for P. vivax and 3.0 (95% CI: 1.7-5.4) for P. falciparum (both P < .001). Splenectomized patients had greater risk of being hospitalized for any cause (AHR = 1.8 [95% CI: 1.0-3.0], P = .037) and diarrheal (AHR = 3.5 [95% CI: 1.3-9.6], P = .016). In the 14-month prospective cohort, 12 episodes of P. vivax and 6 episodes of P. falciparum were observed in 11 splenectomised patients. CONCLUSIONS: Splenectomy is associated with a high risk of malaria, greater for P. vivax than P. falciparum. Eradication of P. vivax hypnozoites using primaquine (radical cure) and subsequent malaria prophylaxis is warranted following splenectomy in malaria-endemic areas.
引用
- Kho S, Andries B, Poespoprodjo JR, et al. High Risk of Plasmodium vivax Malaria Following Splenectomy in Papua, Indonesia. Clin Infect Dis. 2019. PMID: 29771281. doi:10.1093/cid/ciy403
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。